GB0111146D0 - Methods - Google Patents
MethodsInfo
- Publication number
- GB0111146D0 GB0111146D0 GBGB0111146.7A GB0111146A GB0111146D0 GB 0111146 D0 GB0111146 D0 GB 0111146D0 GB 0111146 A GB0111146 A GB 0111146A GB 0111146 D0 GB0111146 D0 GB 0111146D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0111146.7A GB0111146D0 (en) | 2001-05-04 | 2001-05-04 | Methods |
CA002483658A CA2483658A1 (en) | 2001-05-04 | 2002-05-07 | Bont/e or snap-25e for treating botulinum toxin a or c1 poisoning and inhibiting muscle contraction |
EP02720315A EP1418938A1 (en) | 2001-05-04 | 2002-05-07 | Bont/e or snap-25e for treating botulinum toxin a or c1 poisoning and inhibiting muscle contraction |
PCT/GB2002/002087 WO2002089834A1 (en) | 2001-05-04 | 2002-05-07 | Bont/e or snap-25e for treating botulinum toxin a or c1 poisoning and inhibiting muscle contraction |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0111146.7A GB0111146D0 (en) | 2001-05-04 | 2001-05-04 | Methods |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0111146D0 true GB0111146D0 (en) | 2001-06-27 |
Family
ID=9914167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0111146.7A Ceased GB0111146D0 (en) | 2001-05-04 | 2001-05-04 | Methods |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1418938A1 (en) |
CA (1) | CA2483658A1 (en) |
GB (1) | GB0111146D0 (en) |
WO (1) | WO2002089834A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2857098B1 (en) * | 2003-07-04 | 2006-05-05 | Inst Nat Sante Rech Med | METHOD FOR THE EVIDENCE OF A MOLECULAR EVENT IN A CELL USING FLUORESCENT MARKER PROTEINS |
US7172764B2 (en) | 2003-11-17 | 2007-02-06 | Allergan, Inc. | Rescue agents for treating botulinum toxin intoxications |
WO2006011966A1 (en) * | 2004-06-30 | 2006-02-02 | Allergan, Inc. | Optimizing expression of active botulinum toxin type e |
ES2356883B1 (en) * | 2008-07-24 | 2012-02-22 | Bcn Peptides, S.A. | COMPOSITION FOR THE TREATMENT OF PAIN AND / OR INFLAMMATION. |
WO2010022979A1 (en) * | 2008-08-29 | 2010-03-04 | Merz Pharma Gmbh & Co. Kgaa | Clostridial neurotoxins with altered persistency |
US9216210B2 (en) | 2013-12-23 | 2015-12-22 | Dublin City University | Multiprotease therapeutics for chronic pain |
MX2019011196A (en) * | 2017-03-22 | 2020-01-20 | Bonti Inc | Botulinum neurotoxins for use in therapy. |
EP3600385A4 (en) * | 2017-03-22 | 2021-04-07 | Bonti, Inc. | Botulinum neurotoxins for treating traumatic injuries |
GB201815844D0 (en) * | 2018-09-28 | 2018-11-14 | Ipsen Biopharm Ltd | Therapeutic & comestic uses of botulinum neurotoxin serotype e |
US20230405098A1 (en) * | 2022-06-16 | 2023-12-21 | Innomed Technologies, Inc. | Type e botulinum toxin to treat botulism |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69435194D1 (en) * | 1993-12-28 | 2009-04-16 | Allergan Sales Inc | Use of botulinum toxin type B for the manufacture of a medicament for reducing pain due to muscle disease |
US6169074B1 (en) * | 1996-03-18 | 2001-01-02 | The Regents Of The University Of California | Peptide inhibitors of neurotransmitter secretion by neuronal cells |
US6214602B1 (en) * | 1998-08-28 | 2001-04-10 | Promega Corporation | Host cells for expression of clostridial toxins and proteins |
WO2001018038A2 (en) * | 1999-08-20 | 2001-03-15 | Imperial College Innovations Limited | Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
EP2267009B1 (en) * | 1999-08-25 | 2014-10-29 | Allergan, Inc. | Activatable recombinant neurotoxins |
-
2001
- 2001-05-04 GB GBGB0111146.7A patent/GB0111146D0/en not_active Ceased
-
2002
- 2002-05-07 CA CA002483658A patent/CA2483658A1/en not_active Abandoned
- 2002-05-07 WO PCT/GB2002/002087 patent/WO2002089834A1/en not_active Application Discontinuation
- 2002-05-07 EP EP02720315A patent/EP1418938A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2483658A1 (en) | 2002-11-14 |
EP1418938A1 (en) | 2004-05-19 |
WO2002089834A1 (en) | 2002-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0108968D0 (en) | Methods | |
GB0104948D0 (en) | Novel methods | |
GB0120042D0 (en) | Methods | |
GB0126251D0 (en) | Methods | |
GB0111146D0 (en) | Methods | |
GB0116249D0 (en) | Methods | |
GB0127837D0 (en) | Louspeaker | |
GB0124577D0 (en) | Novel methods | |
GB0123494D0 (en) | Polynormial pre-disorter | |
GB0227332D0 (en) | Mailer-ID | |
GB0119103D0 (en) | Travelbib | |
GB0118549D0 (en) | Methods | |
GB0118611D0 (en) | Methods | |
GB0112539D0 (en) | Sleepover | |
GB0116076D0 (en) | Methods | |
HRPK20010394B1 (en) | Nauticbike | |
GB0104012D0 (en) | Neutreena | |
GB0111637D0 (en) | Methods | |
GB0127625D0 (en) | Methods | |
GB0119344D0 (en) | Methods | |
GB0117633D0 (en) | Methods | |
GB0100941D0 (en) | Methods | |
GB0122697D0 (en) | Methods | |
GB0108227D0 (en) | Methods | |
GB0112256D0 (en) | Methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |